EFFEXOR

This brand name is authorized in Canada, France, Japan, Tunisia, United States

Active ingredients

The drug EFFEXOR contains one active pharmaceutical ingredient (API):

1 Venlafaxine UNII 7D7RX5A8MO - VENLAFAXINE HYDROCHLORIDE

Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system. Read about Venlafaxine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EFFEXOR XR Extended-release capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX16	Venlafaxine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02237279, 02237280, 02237282
Country: FR	Base de données publique des médicaments	Identifier(s): 61403425, 66430942
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179055N1021, 1179055N2028
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5803073, 5803074
Country: US	FDA, National Drug Code	Identifier(s): 0008-0833, 0008-0836, 0008-0837, 55289-277, 61919-938, 70518-2156, 70518-2157